[As far as I can work out this may be a trial
of Campath-1H - see:
March 31st, 2003
Orlando Business Journal
Phase II clinical trials designed to evaluate a cancer drug in patients with multiple sclerosis are under way now in nine cities, including Orlando.
Researchers say the drug may have the potential to slow or stop the progression of multiple sclerosis.
Metro Orlando is one of only nine cities in the nation in which this trial is being conducted, and patients are needed.
Dr. Daniel Jacobs of Neurological Services of Orlando is conducting the studies in Orlando. He is one of 20 neurologists worldwide administering the study.
Multiple sclerosis patients who are interested in learning more should
call Sharon Parrisch-Kach at (407) 540-1097.
© 2003 American City Business Journals Inc.